Unknown PHASE3 INTERVENTIONAL 2-arm NCT05418452

Efficacy of 1% Metformin Gel Mixed With PRF in Augmenting Narrow Ridge (MF)

Efficacy of 1% Metformin Gel Mixed With PRF in Augmenting Narrow Ridge With Split-crest Technique and Implant Installation

Sponsor: Al-Azhar University

Conditions Horizontal Ridge Deficiency

Interventions Metformin

Updated 3 times since 2022 Last updated: Jun 12, 2022 Started: Jun 15, 2022 Primary completion: Jun 15, 2023 Completion: Jun 15, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05418452, this PHASE3 trial focuses on Horizontal Ridge Deficiency and remains ongoing. Sponsored by Al-Azhar University, it has been updated 3 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Recruiting → Unknown
Jul 2022 — Jul 2024 [monthly]

Recruiting PHASE3

First recorded

Jun 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Al-Azhar University

Data source: Al-Azhar University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt